Finch Therapeutics Group
(OTC) FNCH
Finch Therapeutics Group Financials at a Glance
Market Cap
$16.94MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$2.85M
Net Income (TTM)
-$14.17M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
0.60 (Low)
Dividend
$0.00
Beta (Volatility)
0.60 (Low)
Price
$10.55
Volume
215
Open
$10.55
Price
$10.55
Volume
215
Open
$10.55
Previous Close
$10.55
Daily Range
$10.55 - $10.55
52-Week Range
$2.00 - $16.10
Estimated Earnings Date
May 14, 2024
Dividend
$0.00
Beta (Volatility)
0.60 (Low)
Price
$10.55
Volume
215
Open
$10.55
Previous Close
$10.55
Daily Range
$10.55 - $10.55
52-Week Range
$2.00 - $16.10
Estimated Earnings Date
May 14, 2024
FNCH News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Finch Therapeutics Group
Industry
Biotechnology
Sector
Health CareEmployees
1
CEO
Matthew P. Blischak
Website
www.finchtherapeutics.comHeadquarters
Boston, MA 02109, US
FNCH Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-86.83%
Return on Capital
-51.15%
Return on Assets
-27.89%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$16.94MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
1.61M
Volume
215
Avg. Volume
4.58K
Financials (TTM)
Gross Profit
-$183.00K
Operating Income
-$19.74M
EBITDA
-$19.51M
Operating Cash Flow
-$18.06M
Capital Expenditure
$14.00K
Free Cash Flow
-$18.04M
Cash & ST Invst.
$16.04M
Total Debt
$28.99M
Finch Therapeutics Group Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$44.00K
+22.8%
Gross Margin
0.00%
N/A
Market Cap
$16.94MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$16.94M
N/A
Employees
1
N/A
Net Income
-$4.83M
+30.4%
EBITDA
-$6.07M
+32.8%
Quarterly Fundamentals
Total Cash
$16.04M
-52.9%
Total Debt
$28.99M
-6.6%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$26.90M
-54.2%
Short Term Debt
$4.19M
+26.4%
Return on Assets
-27.89%
N/A
Return on Invested Capital
-40.49%
N/A
Free Cash Flow
-$4.73M
+48.4%
Operating Cash Flow
-$4.73M
+48.4%